Award
National Cancer Institute 1R01CA300715-01
Mitigating the Impact of Obesity on Endometrial Intraepithelial Neoplasia and Cancer with Incretin Mimetics
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$658,093.00
Ceiling
$658,093.00
Awarded
July 14, 2026
Identifier
1R01CA300715-01
Research grant awarded by NIH/NCI to study the effects of incretin mimetics on obesity-related endometrial cancer and intraepithelial neoplasia through pre-clinical and clinical studies.
Description
This is a research grant project funded by the NIH/NCI. The project involves pre-clinical and clinical studies on obesity and endometrial cancer, focusing on pharmacotherapy and dietary interventions. The project aims to demonstrate the efficacy of incretin-based therapies in reducing tumor growth and obesity-related risk factors.